The maintenance of balance between nitric oxide (NO) and the superoxide anion is required for proper functioning of the endothelium. To investigate the relationship between genetic factors associated with endothelial function and the development of coronary artery disease (CAD), endothelial nitric oxide synthase (ecNOS) gene a/b polymorphism and NADH/NADPH oxidase p22 phox gene C242T polymorphism were examined in 305 Korean male CAD patients and 215 healthy male control subjects. The ␤-fibrinogen gene H1/H2 polymorphism was also analyzed. Both ecNOS a/b and p22 phox C242T polymorphisms were found to be associated with the development of CAD in the study population (p = 0.020 and 0.011, respectively). When the association was analyzed by age, statistical significance was retained only in those Ͻ51 years (p = 0.021 and 0.025 for the a/b and the C242T polymorphism, respectively) and not in those Ͼ51 years of age (p =0.155 and 0.278 respectively). However, the distribution of the ␤-fibrinogen H1/H2 genotypes was not found to be associated with the development of CAD in either the Յ50 (p = 0.611) or Ͼ50 groups (p = 0.188). The ecNOS gene a/b polymorphism and the NADH/NADPH oxidase p22 phox gene C242T polymorphism were found to be significantly associated with the development of CAD in Korean male patients less than 51 years old.
Introduction
Nitric oxide (NO) is one of the major molecules responsible for vascular regulation. It mediates endothelium-dependent vasodilatation, inhibits smooth muscle cell proliferation and the adhesion of platelets and monocytes to the endothelium, and plays a role as an oxygen radical scavenger. [1] [2] [3] These essential roles of NO in vascular regulation suggest that a derangement in endothelial NO synthesis might lead to the development of atherosclerosis. 4 It has been reported that the endothelial nitric oxide synthase (ecNOS) gene a/b polymorphism caused by four (allele ecNOSa) or five (allele ecNOSb) repeats of a 27 base pair sequence in intron 4 of the ecNOS gene is associated with the risk of coronary artery disease (CAD) and acute myocardial infarction (AMI). Moreover, the effect of cigarette smoking on the severity of CAD was greater in ecNOSa homozygotes than in heterozygotes or in ecNOSb homozygotes. 5, 6 Although it is not known whether the ecNOS a/b polymorphism is associated with variations in the expression level or the functional activity of ecNOS, a recent report by Tsukada et al demonstrated that the presence of the ecNOSa allele is associated with a decrease in the level of plasma NO metabolites. 7 The effective concentration of NO in a given biological tissue is determined not only by its rate of enzymatic formation, but also by its rate of degradation and the rate at which it is scavenged by other biomolecules. In atherosclerotic plaques, increases in oxidative stress within the vascular wall lead to an accelerated breakdown of NO. 8, 9 Superoxide anion is one of the major oxygen-derived metabolites capable of inactivating NO, by causing the formation of peroxynitrite, 10 and oxidative stress in the vasculature induced by the superoxide anion has been implicated in the pathogenesis of CAD. 8 Free radicals also diminish the endothelial synthesis of NO by inhibiting the activity of dimethylarginine dimethylaminohydrolase (DDAH), which is responsible for the degradation of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of NOS.
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NADH/NADPH oxidase is a key enzyme in the production of superoxide in the vasculature and in macrophages, vascular smooth muscle cells, and endothelial cells. 12, 13 An essential component of NADH/NADPH oxidase, p22 phox, is one of the electron transfer elements of this enzyme. 14 The C242T polymorphism changes histidine-72 to tyrosine, which is located in the potential heme-binding site, and was shown to be related to the risk of CAD in the Japanese population. 15 Recently, it has been reported that 242C homozygotes have significantly blunted endotheliumdependent dilator responses, which are independent of the other risk factors of atherosclerosis. 16 An increasing amount of experimental and clinical data demonstrates that endothelial dysfunction is encountered during the normal physiological process of aging. Various studies employing elderly human and experimental animals have indicated that the aging vascular endothelium suffers a reduction in its responsiveness to external stimuli, which results in an impairment of NO-mediated vasodilation. [17] [18] [19] For example, in rats, the basal and stimulated release of NO by the coronary endothelium deteriorates with aging. 20 Structural changes associated with the aging process also result in endothelial dysfunction. Aged vasculature shows an accumulation of extracellular matrix, increased collagen content, and the disorganization of elastin fibers, all of which can lead to an increase in the lumen diameter, kinking of arteries, and increased rigidity of the arterial wall. 21, 22 These structural and functional changes in aging vasculature are believed to be responsible for the endothelial dysfunction observed in elderly subjects.
We recently reported that the association between the ecNOS a/b polymorphism and the occurrence of AMI is influenced by age in the Korean male. 23 This raised the possibility that aging may influence the genetic factors associated with endothelial dysfunction in the development of CAD. To investigate this hypothesis, we analyzed the distribution of the ecNOS a/b and p22 phox C242T alleles in different age groups in Korean male CAD patients and compared the results with those of normal control subjects. We also analyzed the ␤-fibrinogen H1/H2 polymorphism, which has been shown to be associated with plasma fibrinogen levels. 24, 25 Our results indicate that the ecNOS gene a/b polymorphism and the NADH/NADPH oxidase p22 phox gene C242T polymorphism are significantly associated with the development of CAD in Korean male patients.
Materials and methods

Selection of patients and control population
A total of 305 unrelated Korean male CAD patients between the ages of 20 and 80 years who received coronary angiography in the Samsung Medical Center (SMC) between 1994 and 1997 were included in the study. The CAD group consisted of 139 patients with previous myocardial infarction (MI) or AMI, 78 patients with unstable angina, and 88 patients with stable angina pectoris. The diagnosis of AMI was based on typical chest pain, the Qwave, Ն0.1 mm ST segment elevation on more than two contiguous leads on an echocardiogram and creatine kinase myocardial band 'CK-MB' elevations. Stable angina was defined as the presence of effort angina with a stable pattern over the previous 3 months, with angiographically documented significant CAD. Unstable angina was defined as either angina pain of recent onset, that is, within 6 weeks, brought on by minimal exertion or more severe, prolonged, or more frequent anginal attacks superimposed on chronic effort angina. All CAD patients had more than 70% luminal narrowing in at least one vessel.
The male control subjects, selected from individuals who came to the health promotion center for a medical checkup, were healthy male individuals without any history or diagnosis of CAD. They were genetically unrelated and selected randomly for the current study after informed consent was obtained.
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The investigation conformed with the principles outlined in the Declaration of Helsinki.
Identification of gene polymorphism
DNA was extracted from WBCs by a method described by Miller et al. 26 The extracted DNA was stored at 4°C until analysis. Polymerase chain reaction (PCR) analysis was used to characterize ecNOS a/b polymorphism and PCRrestriction fragment length polymorphism (RFLP) analysis for the p22 phox C242T and ␤-fibrinogen H1/H2 polymorphism. The oligonucleotide primers and PCR reactions for the ecNOS a/b polymorphism were conducted as described by Wang et al ( Figure 1A ). 5 To detect the p22 phox C242T polymorphism, a 257 bp PCR-product spanning 487 to 744 bp from the transcription start site (from intron 3 to exon 4) was amplified: the initial cycle consisted of 94°C for 5 min, 55°C for 1 min and 72°C for 5 min, and this was followed by 45 cycles of 94°C for 1 min, 55°C for 30 s and 72°C for 1 min. The oligonucleotide primers used were 5Ј-TGGTTTCTCACTTGGAGGCT-3Ј and 5Ј-CGGCCCG-AACATAGTAATTC-3Ј on the coding and non-coding strands of the DNA, respectively. Digestion of the PCR product with Rsa I resulted in 198 and 59 bp fragments for the C allele ( Figure 1B) .
The H1/H2 alleles in the ␤-fibrinogen gene were identified by PCR followed by Hae III digestion of the amplified DNA. A portion of the ␤-fibrinogen gene from −680 bp from the start of transcription to +121 bp was amplified by PCR. The initial cycle consisted of 94°C for 2 min, 55°C for 1 min and 72°C for 1 min, and this was followed by 30 cycles of 94°C for 1 min, 55°C for 30 s and 72°C for 45 s. The oligonucleotide primers used were: 5Ј-AAAAAG-GGTCTTTCTGATGTGTA-3Ј and 5Ј-TCCTCATTGTCG-TTGACACCT-3Ј on the coding and non-coding strands of the DNA, respectively. The fragment amplified was therefore 701 bp in length. A total of 5-10 l of PCR product was digested with the restriction enzyme Hae III, which digested the fragment representing the H1 allele (guanine at −453 bp) into a 574 bp and a 127 bp fragment, but not the fragment representing the H2 allele (adenine at −453 bp) ( Figure 1C ). The DNA fragments were separated in 2% agarose gels by electrophoresis in TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 7.7) containing 0.5 g/ml ethidium bromide and visualized under ultraviolet light.
Measurement of plasma fibrinogen levels
Plasma fibrinogen levels were determined using methods described by Scarabin et al 27 and are reported in mg/dl.
Statistical analysis
The Mann-Whitney U test and Kruskal Wallis one-way ANOVA were used for group comparisons. The frequencies of the alleles and genotypes of the different subgroups were compared using the chi-squared test. In all statistical analyses, a p-value of less than 0.05 was considered to be statistically significant. Calculations for obtaining 95% confidence intervals for odds ratios were based on the natural logarithms of the odds ratio. 
Results
Females were excluded from our study because young female CAD patients (under the age of 51) constitute less than 5% of all female CAD patients. The demographic and clinical features of the study subjects are listed in Table 1 . When compared with the control subjects, the patient population was found to have a higher incidence of ex-smokers and patients with a history of diabetes mellitus and hypertension.
EcNOS gene a/b polymorphism A significant association was found between the ecNOS a/b polymorphism and the risk of CAD (p = 0.02) ( Table 2) . The patients had a higher level of ecNOS a/a homozygotes and fewer ecNOS a/b heterozygotes than the controls, which is in agreement with the genotype distribution pattern in CAD patients in an Australian study. 5 We then investigated the association between the ecNOS a/b polymorphism and CAD with respect to age by separating the subjects into two groups: a group of 50 years old and younger and an over-50 age group. Only the Յ50 group showed a significant deviation in the ecNOS a/b genotype distribution from the corresponding control population (p = 0.021). The distribution of genotypes for both CAD and control groups was in Hardy-Weinberg equilibrium ( 2 = 1.94 and 0.55 respectively). The presence or absence of other risk factors such as hypertension, cholesterol, or diabetes did not affect the ecNOS a/b genotype distribution in a statistically significant manner (data not shown).
NADH/NADPH oxidase p22 phox gene polymorphism
Frequencies of the p22 phox CC, CT, and TT genotypes are listed in Table 3 . The frequencies of each genotype in the CAD and control groups are similar to those found in the Japanese population, as reported by Inoue et al. 15 A significant difference was found in the genotype distributions of the control subjects and the CAD patients (p = 0.011) ( Table 3 ). The odds ratio of the CC versus TC + TT genotype of the C242T polymorphism in the control subjects and the CAD patients was 1.798 (95% CI, 1.146 to 2.818) (p = 0.01). When the association between the p22 phox C242T polymorphism and CAD was analyzed in the different age groups, only the patients Յ50 showed a significant alteration in the p22 phox C242T genotype distribution compared to the Ͻ50 control group (p = 0.025). The distribution of genotypes for both the CAD and the control groups was in Hardy-Weinberg equilibrium ( 2 = 0.61 and 0.55 respectively). The presence or absence of other risk factors such as hypertension, cholesterol, or diabetes were not statistically related to C242T genotype distribution (data not shown).
␤-Fibrinogen gene polymorphism and CAD
In contrast to the ecNOS a/b and the p22 phox C242T polymorphisms, the ␤-fibrinogen H1/H2 allele distribution was not statistically different in the control and the CAD groups. When the allelic distribution was tested in the different age groups, no statistically significant differences were found between the Յ50 and Ͼ50 age groups ( Table 4 ). The H1/H2 genotype distribution in the study population was in agreement with previously published reports, 25, 28 and the distribution of genotypes for both the CAD and the control groups was in Hardy-Weinberg equilibrium ( 2 = 0.03 and 0.35 respectively). The H1/H2 alleles of the ␤-fibrinogen gene are known to be associated with plasma fibrinogen levels in smokers. 25, 28 In our study population, the CAD group showed higher plasma fibrinogen levels (mean Ϯ SD: 355.8 Ϯ 124.6 mg/dl) than the normal population (312.8 Ϯ 55.52, p Ͻ 0.0001) (Figure 2) . Furthermore, the plasma fibrinogen levels of the CAD patients with the H2H2 genotype (419.1 Ϯ 82.70) were higher than those of CAD patients with the H1H1 genotype (351.1 Ϯ 117.9, p Ͻ 0.05). The plasma fibrinogen levels in normal subjects with the H1H1 and H2H2 genotypes were not significantly different. 
Discussion
The development of CAD is influenced by the aging process. Among known CAD patients, patients of 50 years old and younger comprise less than 25% of the CAD population in Korea. Furthermore, most of the younger CAD patients are male. Women CAD patients were excluded from our study because the number of women patients with CAD is relatively small, especially amongst those Յ50 years.
Our results suggest that both ecNOS a/b and p22 phox C242T polymorphisms are associated with the development of CAD in a younger population but not in the older population. The investigation into possible interrelationships between these two polymorphisms in the development of CAD revealed that ecNOS a/b and p22 phox C242T polymorphisms do not show synergism. However, it should be noted that the numbers of patients involved in this study were relatively small for a genetic association study, and therefore the conclusions are not as secure as they would have been with a large study population. Furthermore, it is possible that ethnic differences exist in the association between polymorphisms and clinical phenotypes.
CAD patients have elevated plasma fibrinogen levels. 25, 28 The H1/H2 polymorphism of the ␤-fibrinogen gene affects plasma fibrinogen levels and fibrinogen is known to be an independent risk factor for CAD. This may raise the possibility that the ␤-fibrinogen H1/H2 polymorphism is associated with the development of CAD. To test this possibility, we analyzed our study population and found that CAD patients did have higher plasma fibrinogen levels than the control group. CAD patients with the ␤-fibrinogen H2H2 genotype had higher plasma fibrinogen levels than H1H1 patients, but the ␤-fibrinogen H1/H2 polymorphism failed to show any significant association with the development of CAD in both the total and the Յ50 group. However, an alternative explanation that should be noted is that our failure to find any association between the fibrinogen polymorphism and the development of CAD is a type II statistical error due to the small number of patients in this study. What is the possible explanation for this effect of age on the association between gene polymorphisms and the development of CAD? Recent developments in vascular biology may provide some answers. In healthy humans, total body NO production appears to decrease in old age, on the basis of measurements of serum NO metabolite levels. Furthermore, NO-mediated vasodilation is also impaired in old age. 19 The analysis of rabbits and rats indicates that the levels of iNOS (inducible NOS) and ecNOS proteins are increased in aged animals, but that NO-mediated vasodilation was nevertheless impaired. 17, 18 Further analysis revealed that the production of NO in the aged endothelium after either hyperemia or acetylcholine infusion did not increase as efficiently as in the young endothelium, indicating that some alterations occurred either in the signaling events that are responsible for the activation of ecNOS or in the ecNOS activity itself. Haas et al reported that the reduction in the response of aged endothelium after acetylcholine infusion was caused by a reduction of Ca ++ influx into the aged endothelial cells upon stimulation, rather than any changes in the activity of ecNOS. 18 This means that the reduction in the responsiveness of the aged artery is caused by something in the signaling pathway rather than by ecNOS activity changes. This may explain why the ecNOS polymorphism had a smaller effect on the development of CAD in the aged population. Alternatively, it may be that structural changes in the aged artery may mask the effects of the ecNOS polymorphism. The changes in the vasculature associated with aging 21, 22 impair the endothelial responsiveness in such a way that the minor changes associated with the ecNOS a/b polymorphism might not be significant in the old population. Another possibility for the effect of aging on the association between gene polymorphisms and the development of CAD may be due to the loss over time of individuals with ecNOSa and C242 alleles. If these individuals are more likely to develop premature CAD, then more of them are likely to die at a young age, and so there is a depletion of these alleles from the older age groups.
